<VariationArchive VariationID="190219" VariationName="NM_007254.4(PNKP):c.1221_1223del (p.Thr408del)" VariationType="Deletion" Accession="VCV000190219" Version="36" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="6" DateLastUpdated="2024-06-23" DateCreated="2015-05-09" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="188053" VariationID="190219">
      <GeneList>
        <Gene Symbol="PNKP" FullName="polynucleotide kinase 3'-phosphatase" GeneID="11284" HGNC_ID="HGNC:9154" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="49861204" stop="49867576" display_start="49861204" display_stop="49867576" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="50364459" stop="50370821" display_start="50364459" display_stop="50370821" Strand="-" />
          </Location>
          <OMIM>605610</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_007254.4(PNKP):c.1221_1223del (p.Thr408del)</Name>
      <CanonicalSPDI>NC_000019.10:49861846:GTGGT:GT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="49861847" stop="49861849" display_start="49861847" display_stop="49861849" variantLength="3" positionVCF="49861846" referenceAlleleVCF="CGTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="50365104" stop="50365106" display_start="50365104" display_stop="50365106" variantLength="3" positionVCF="50365103" referenceAlleleVCF="CGTG" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>chr19-49861847-GTG-</Name>
        <Name>p.Thr408del</Name>
      </OtherNameList>
      <ProteinChange>T408del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.49861849_49861851del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.49861849_49861851del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.50365106_50365108del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.50365106_50365108del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027717.1" sequenceAccession="NG_027717" sequenceVersion="1" change="g.10717_10719del">
            <Expression>NG_027717.1:g.10717_10719del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_050666.1" sequenceAccession="NG_050666" sequenceVersion="1" change="g.18006_18008del">
            <Expression>NG_050666.1:g.18006_18008del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007254.4" sequenceAccession="NM_007254" sequenceVersion="4" change="c.1221_1223del" MANESelect="true">
            <Expression>NM_007254.4:c.1221_1223del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009185.2" sequenceAccession="NP_009185" sequenceVersion="2" change="p.Thr408del">
            <Expression>NP_009185.2:p.Thr408del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA199622" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="605610.0007" DB="OMIM" />
        <XRef Type="rs" ID="786205207" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_007254.4(PNKP):c.1221_1223del (p.Thr408del) AND Ataxia - oculomotor apraxia type 4" Accession="RCV000170438" Version="4">
        <ClassifiedConditionList TraitSetID="20954">
          <ClassifiedCondition DB="MedGen" ID="C4225397">Ataxia - oculomotor apraxia type 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-04-09" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007254.4(PNKP):c.1221_1223del (p.Thr408del) AND Microcephaly, seizures, and developmental delay" Accession="RCV000500375" Version="6">
        <ClassifiedConditionList TraitSetID="1332">
          <ClassifiedCondition DB="MedGen" ID="C3150667">Microcephaly, seizures, and developmental delay</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-07" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007254.4(PNKP):c.1221_1223del (p.Thr408del) AND Charcot-Marie-Tooth disease type 2B2" Accession="RCV001093540" Version="4">
        <ClassifiedConditionList TraitSetID="354">
          <ClassifiedCondition DB="MedGen" ID="C1854150">Charcot-Marie-Tooth disease type 2B2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-20" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007254.4(PNKP):c.1221_1223del (p.Thr408del) AND Developmental and epileptic encephalopathy, 12" Accession="RCV001226527" Version="8">
        <ClassifiedConditionList TraitSetID="6739">
          <ClassifiedCondition DB="MedGen" ID="C3150988">Developmental and epileptic encephalopathy, 12</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007254.4(PNKP):c.1221_1223del (p.Thr408del) AND not provided" Accession="RCV001268911" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-10-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-14" NumberOfSubmissions="7" NumberOfSubmitters="6" DateCreated="2015-05-09" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25728773</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27066567</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30039206</ID>
        </Citation>
        <DescriptionHistory Dated="2020-11-27">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-08-27">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="20954" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="33013" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ataxia-oculomotor apraxia 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ataxia - oculomotor apraxia type 4</ElementValue>
                <XRef ID="MONDO:0014557" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AOA4</ElementValue>
                <XRef Type="MIM" ID="616267" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13111" />
                <XRef ID="13111" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="459033" DB="Orphanet" />
              <XRef ID="C4225397" DB="MedGen" />
              <XRef ID="MONDO:0014557" DB="MONDO" />
              <XRef Type="MIM" ID="616267" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="354" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="778" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease type 2B2</ElementValue>
                <XRef ID="MONDO:0011570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CMT 2B2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth disease, axonal, Type 2B2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth disease, neuronal, Type 2B2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth disease, axonal, autosomal recessive, B2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth Neuropathy Type 2B2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2B2</ElementValue>
                <XRef Type="MIM" ID="605589" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMT2B2</ElementValue>
                <XRef Type="MIM" ID="605589" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ARCMT2B</ElementValue>
                <XRef Type="MIM" ID="605589" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1249" />
                <XRef ID="1249" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="101101" DB="Orphanet" />
              <XRef ID="C1854150" DB="MedGen" />
              <XRef ID="MONDO:0011570" DB="MONDO" />
              <XRef Type="MIM" ID="605589" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6739" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15767" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 12</ElementValue>
                <XRef ID="Epileptic+encephalopathy%2C+early+infantile%2C+12/8340" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 12</ElementValue>
                <XRef ID="MONDO:0013389" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE12</ElementValue>
                <XRef Type="MIM" ID="613722" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13318" />
                <XRef ID="13318" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3150988" DB="MedGen" />
              <XRef ID="MONDO:0013389" DB="MONDO" />
              <XRef Type="MIM" ID="613722" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1332" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6933" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Microcephaly, seizures, and developmental delay</ElementValue>
                <XRef ID="MONDO:0013254" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 10</ElementValue>
                <XRef ID="Epileptic+encephalopathy%2C+early+infantile%2C+10/8338" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EIEE10</ElementValue>
                <XRef Type="MIM" ID="613402" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MCSZ</ElementValue>
                <XRef Type="MIM" ID="613402" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10933" />
                <XRef ID="10933" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="C3150667" DB="MedGen" />
              <XRef ID="MONDO:0013254" DB="MONDO" />
              <XRef Type="MIM" ID="613402" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="389381" SubmissionDate="2020-05-08" DateLastUpdated="2020-05-12" DateCreated="2015-03-24">
        <ClinVarSubmissionID localKey="605610.0007_ATAXIA-OCULOMOTOR APRAXIA 4" title="PNKP, 3-BP DEL, NT1221 (rs770849181)_ATAXIA-OCULOMOTOR APRAXIA 4" />
        <ClinVarAccession Accession="SCV000218380" DateUpdated="2020-05-12" DateCreated="2015-03-24" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-03-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Ataxia-Oculomotor Apraxia 4</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 unrelated Portuguese patients with ataxia-oculomotor apraxia-4 (AOA4; 616267), Bras et al. (2015) identified a heterozygous 3-bp deletion (c.1221_1223del) in the PNKP gene, resulting in the deletion of residue thr408 (Thr408del). Each patient had a truncating mutation in the PNKP gene on the other allele (see, e.g., 605610.0008). The mutations segregated with the disorder in the families; functional studies of the variants were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">25728773</ID>
              </Citation>
              <XRef DB="OMIM" ID="616267" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Charcot-Marie-Tooth Disease, Axonal, Type 2B2</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 17-year-old Brazilian boy with Charcot-Marie-Tooth disease type 2B2 (CMT2B2; 605589), Pedroso et al. (2015) identified a homozygous Thr408del mutation in the PNKP gene. The mutation, which was found by whole-exome sequencing, was heterozygous in the unaffected parents. In vitro functional expression studies showed that patient fibroblasts were more sensitive to genotoxic chemical injury compared to control fibroblasts. Patient cells showed increased apoptosis, increased caspase-3 (CASP3; 600636) activity, a disruption of cell cycle dynamics, and evidence of DNA damage. The findings indicated that the mutation rendered the cells unable to efficiently repair DNA for both base-excision repair (BER) and nonhomologous end-joining (NHE) pathways.</Attribute>
              <Citation>
                <ID Source="PubMed">27066567</ID>
              </Citation>
              <XRef DB="OMIM" ID="605589" Type="MIM" />
              <XRef DB="OMIM" ID="600636" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">For discussion of the Thr408del mutation in the PNKP gene that was found in compound heterozygous state in 5 unrelated Costa Rican probands with CMT2B2 by Leal et al. (2018), see 605610.0009. Leal et al. (2018) stated that the Thr408del variant, which occurs in exon 14, was present in the gnomAD database (rs770849181) at a low frequency (15 of 214,338 alleles).</Attribute>
              <Citation>
                <ID Source="PubMed">30039206</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <Name>PNKP, 3-BP DEL, NT1221 (rs770849181)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, NT1221 (rs770849181)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605610.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ATAXIA-OCULOMOTOR APRAXIA 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2472193" SubmissionDate="2020-05-08" DateLastUpdated="2020-05-12" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="605610.0007_CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2" title="PNKP, 3-BP DEL, NT1221 (rs770849181)_CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2" />
        <ClinVarAccession Accession="SCV001250589" DateUpdated="2020-05-12" DateCreated="2020-05-12" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-03-05">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Ataxia-Oculomotor Apraxia 4</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 unrelated Portuguese patients with ataxia-oculomotor apraxia-4 (AOA4; 616267), Bras et al. (2015) identified a heterozygous 3-bp deletion (c.1221_1223del) in the PNKP gene, resulting in the deletion of residue thr408 (Thr408del). Each patient had a truncating mutation in the PNKP gene on the other allele (see, e.g., 605610.0008). The mutations segregated with the disorder in the families; functional studies of the variants were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">25728773</ID>
              </Citation>
              <XRef DB="OMIM" ID="616267" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Charcot-Marie-Tooth Disease, Axonal, Type 2B2</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 17-year-old Brazilian boy with Charcot-Marie-Tooth disease type 2B2 (CMT2B2; 605589), Pedroso et al. (2015) identified a homozygous Thr408del mutation in the PNKP gene. The mutation, which was found by whole-exome sequencing, was heterozygous in the unaffected parents. In vitro functional expression studies showed that patient fibroblasts were more sensitive to genotoxic chemical injury compared to control fibroblasts. Patient cells showed increased apoptosis, increased caspase-3 (CASP3; 600636) activity, a disruption of cell cycle dynamics, and evidence of DNA damage. The findings indicated that the mutation rendered the cells unable to efficiently repair DNA for both base-excision repair (BER) and nonhomologous end-joining (NHE) pathways.</Attribute>
              <Citation>
                <ID Source="PubMed">27066567</ID>
              </Citation>
              <XRef DB="OMIM" ID="605589" Type="MIM" />
              <XRef DB="OMIM" ID="600636" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">For discussion of the Thr408del mutation in the PNKP gene that was found in compound heterozygous state in 5 unrelated Costa Rican probands with CMT2B2 by Leal et al. (2018), see 605610.0009. Leal et al. (2018) stated that the Thr408del variant, which occurs in exon 14, was present in the gnomAD database (rs770849181) at a low frequency (15 of 214,338 alleles).</Attribute>
              <Citation>
                <ID Source="PubMed">30039206</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <Name>PNKP, 3-BP DEL, NT1221 (rs770849181)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, NT1221 (rs770849181)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605610.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3864842" SubmissionDate="2021-10-05" DateLastUpdated="2022-03-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="SUB10428787" submittedAssembly="GRCh38" title="SUB10428787" />
        <ClinVarAccession Accession="SCV001934609" DateUpdated="2022-03-28" DateCreated="2022-03-28" Type="SCV" Version="1" SubmitterName="Laboratório de Neurologia Aplicada e Experimental, Faculdade de Medicina de Ribeirao Preto – Universidade de Sao Paulo" OrgID="508238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">30039206</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">27066567</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">25728773</ID>
          </Citation>
          <Comment>The variant p.Thr408Del variant in the PNKP gene has been observed in patients with CMT2B2 and ataxia with oculomotor apraxia type 4. ClinVar classifies this variant as Pathogenic (Variation ID: 190219), 2 stars (multiple consistent, 6 submissions), citing 3 articles (30039206, 27066567 and 25728773). This variant is present in heterozygous in 15 alleles in the GnomAD database and absents in the ABraOM database. This variant deletes one amino acid of the PNKP protein, which is highly conserved across different species. This variant is in an important functional domain of the protein (Kinase). In summary, the p.Thr408Del meets our criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">16</Age>
              <Age Type="maximum" age_unit="years">17</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
              <FamilyData NumFamiliesWithVariant="2" />
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="2" />
            </ObservedData>
            <Comment>Both patients had early symptoms, with one patient having severe CMT2 with mild ataxia without the presence of oculomotor apraxia (PMID: 27066567), while the other patient had moderate CMT2 with ataxia and oculomotor apraxia.</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP">
              <Name>polynucleotide kinase 3'-phosphatase</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_007254.4:exon 14</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Thr408del</Name>
            <Name>chr19-49861847-GTG-</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="rs786205207" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007254.4:c.1221_1223del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605589" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10428787</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="405114" SubmissionDate="2015-04-20" DateLastUpdated="2015-05-09" DateCreated="2015-05-09">
        <ClinVarSubmissionID localKey="NC_000019.9:g.50365104_50365106delGTG|OMIM:616267" />
        <ClinVarAccession Accession="SCV000222876" DateUpdated="2015-05-09" DateCreated="2015-05-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-04-09">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25728773</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.50365104_50365106delGTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ATAXIA-OCULOMOTOR APRAXIA 4</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="616267" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1152942" SubmissionDate="2017-07-05" DateLastUpdated="2017-08-28" DateCreated="2017-08-28">
        <ClinVarSubmissionID localKey="NM_007254.3(PNKP):c.1221_1223del|Microcephaly, seizures, and developmental delay" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000596488" DateUpdated="2017-08-28" DateCreated="2017-08-28" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007254.3:c.1221_1223del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Microcephaly, seizures, and developmental delay</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2843028</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2858548" SubmissionDate="2020-10-23" DateLastUpdated="2020-11-28" DateCreated="2020-11-28">
        <ClinVarSubmissionID localKey="report_configuration_variant_id:538" />
        <ClinVarAccession Accession="SCV001448160" DateUpdated="2020-11-28" DateCreated="2020-11-28" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Unknown mechanism</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SampleLocalID">DX184116</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000657" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001251" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="C" referenceAllele="CGTG" start="50365103" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2733823" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="3126129|MedGen:C3150988" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001398844" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27066567</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25728773</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27066567</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30039206</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects PNKP function (PMID: 27066567). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 190219). This variant has been observed in individual(s) with PNKP-related conditions (PMID: 25728773, 27066567, 30039206; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs786205207, gnomAD 0.05%). This variant, c.1221_1223del, results in the deletion of 1 amino acid(s) of the PNKP protein (p.Thr408del), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.50365104_50365106del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150988" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3864842" TraitType="Disease" MappingType="XRef" MappingValue="605589" MappingRef="OMIM">
        <MedGen CUI="C1854150" Name="Charcot-Marie-Tooth disease type 2B2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2858548" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000657" MappingRef="HP">
        <MedGen CUI="C3489733" Name="Oculomotor apraxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2472193" TraitType="Disease" MappingType="Name" MappingValue="CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2" MappingRef="Alternate">
        <MedGen CUI="C1854150" Name="Charcot-Marie-Tooth disease type 2B2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2858548" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="389381" TraitType="Disease" MappingType="Name" MappingValue="ATAXIA-OCULOMOTOR APRAXIA 4" MappingRef="Preferred">
        <MedGen CUI="C4225397" Name="Ataxia - oculomotor apraxia type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2858548" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="405114" TraitType="Disease" MappingType="Name" MappingValue="ATAXIA-OCULOMOTOR APRAXIA 4" MappingRef="Preferred">
        <MedGen CUI="C4225397" Name="Ataxia - oculomotor apraxia type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2733823" TraitType="Disease" MappingType="XRef" MappingValue="C3150988" MappingRef="MedGen">
        <MedGen CUI="C3150988" Name="Developmental and epileptic encephalopathy, 12" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2858548" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001251" MappingRef="HP">
        <MedGen CUI="C0007758" Name="Cerebellar ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1152942" TraitType="Disease" MappingType="Name" MappingValue="Microcephaly, seizures, and developmental delay" MappingRef="Preferred">
        <MedGen CUI="C3150667" Name="Microcephaly, seizures, and developmental delay" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

